Davide completed his PhD in 2013 at the Karolinska Institutet in Stockholm, Sweden with Mats Wahlgren where he studied virulence mechanisms in P. falciparum malaria. He then joined the laboratory of Jon Yewdell at the National Institute of Allergy and Infectious Diseases (NIAID), NIH in Bethesda, USA as a postdoctoral fellow where he elucidated basic rules of antibody and B cell immunodominance to Influenza A virus.

He joined the Department of Microbiology and Immunology at the University of Gothenburg as an assistant professor in summer 2018 and was promoted to Professor in 2025.

LINKEDIN          ORCID ID

Satabdi earned her Ph.D. from the University of Missouri - Columbia under the supervision of Prof. Wendy Picking in 2025. Her doctoral research focused on the immunological evaluation of a Pseudomonas aeruginosa subunit protein vaccine, with particular emphasis on obesity-associated immune responses and broad-spectrum protection. She previously completed her Bachelor’s and Master’s degrees in Biochemistry from the University of Calcutta. She joined the lab in February 2026 to study lung memory B cell responses in a co-infection model.

LINKEDIN

Zhao-Shan joined the Angeletti Lab as a STINT Fellow in June 2026. She received her PhD from the Chinese Academy of Agricultural Sciences in 2025, where her dissertation was awarded the Best Thesis Prize across China. She subsequently completed a one-year postdoctoral appointment at Umeå University, focusing on the molecular pathogenesis and host-pathogen interactions of blood-stage malaria. Her current research focuses on viral immunology and nanobody engineering, with a particular interest in B-cell biology and the development of broadly neutralizing antibodies against Influenza A virus.

LINKEDIN

Suparna Joined the Angeletti Lab as a SciLifeLab PULSE Marie Skłodowska-Curie Actions (MSCA) Cofund postdoctoral fellow in October 2026. She completed her Ph.D from the Indian Council of Medical Research- National Institute for Research in Bacterial Infections (ICMR- NIRBI) in 2024. During her doctoral tenure, she developed an intranasal vaccine candidate against Salmonella Typhi and Paratyphi A infections, investigating mucosal immune responses and mechanisms underlying enhanced protection. Alongside, she also established an iron-overloaded murine model to investigate gut mucosal immune responses upon Salmonella Paratyphi A infection. Thereafter, she worked as Project Research Scientist I at ICMR- NIRBI for two years, characterizing antibiotic induced Salmonella L form and elucidating associated genetic and epigenetic changes and developed a PCR based detection method for identifying Salmonella L form. Her current research focuses on developing next generation RNA vaccines for broad protection against Influenza A, SARS-Cov2 and emerging variants.

LINKEDIN

Xing-Tian received his PhD degree from Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences (CAAS). Then, he received two-year postdoctoral training at Lanzhou Veterinary Research Institute, CAAS, focusing on the mechanisms of interactions between viral proteins of IAV and host proteins. He was awarded as the excellent postdoc by CAAS. He previously worked as a postdoc at Pirbright Institute. While still employed at CAAS, he joined the Angeletti Lab in 2026 as visiting researcher where he concentrates on the role of adaptive immunity to IAV infection.

ORCID ID

Janarthan completed his master’s degree in biomedical engineering majoring in molecular and cellular biotherapies, from the Paris BME program jointly offered by the Université de Paris, PSL University and ENSAM. He is trained as a physician, completing medical school in 2014 and serving as a clinician for 5 years in several specialties. In February 2021, he joined the Angeletti lab as a doctoral student to study host-pathogen interactions of viral infections, primarily using influenza viruses to elucidate human B cell and antibody immunodominance.

He is also a teaching fellow in the department of microbiology and immunology at the Sahlgrenska Academy, where he receives structured pedagogical training to teach microbiology and immunology.

LINKEDIN

Danica obtained her BSc Specializing in Immunology and Infection in Spring 2018 from the University of Alberta, Canada. In the summer of 2019, she worked as a research laboratory assistant in Dr. David Marchant's lab at the University of Alberta, researching the interaction of RSV with host cells, focusing on the receptors involved. In June 2022, she obtained her MSc in Molecular Biology at Gothenburg University and started her PhD immediately after, now focusing on the antigenicity and immunogenicity of influenza neuraminidase.

LINKEDIN

Romain is a PhD student who joined the lab in September 2022. He obtained his Master in Immunology from Aix-Marseille University and worked in the Gaya lab at the CIML studying Bmem functions following S. aureus infection on the skin. He also worked as an associate researcher in the Lafaille lab at Icahn School at Mount Sinai, studying plasmablast migration during type-2 responses. His project now focuses on characterizing the Bmem compartment in the airways in the context of an IAV infection.

Giacomo firstly joined the lab in January 2025 as a bachelor student, where he worked on the characterization of anti-neuraminidase antibodies as a part of its BSc in Biomedicine from Skövde University. He then joined the lab again in July 2026 as a master student in Immunology & Microbiology from Uppsala University. His project now focuses on germinal centre-like tonsil organoids development, to discover novel antiviral monoclonal antibodies.

Karin went to “Laborantskolan” at the University of Gothenburg where she had her exam in 1986. After a few years in a company (Pharmacia CanAg), working with research in cancer immunotherapy, she joined Nils Lycke’s group in 1993.

Since 2020 Karin joined the lab as research technician, first part time and, as of 2021, full-time.

LINKEDIN